Abstract
Endolichenic fungi (ELF) offer an opportunity to discover emerging natural drugs. ELF are promising bioresources given their ability to produce bioactive metabolites that represent unique and diverse structural classes. Here, we assess the potential of recent technologies to provide insight into the chemical diversity of ELF for biopharmaceutical development.
Original language | English |
---|---|
Pages (from-to) | 808-813 |
Number of pages | 6 |
Journal | Trends in Biotechnology |
Volume | 35 |
Issue number | 9 |
DOIs | |
Publication status | Print publication - Sept 2017 |
Externally published | Yes |